Dendrimers in biomedical sciences and nanotechnology;Dendrymery w naukach biomedycznych i nanotechnologii

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 725-733

  Sękowski, Szymon ^a   Miłowska, Katarzyna ^a   Gabryelak, Teresa ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Biomedicine; Dendrimers; Nanotechnology

Indexed keywords

DENDRIMER;

HUMAN; MEDICAL TECHNOLOGY; NANOTECHNOLOGY; REVIEW;

BIOMEDICAL TECHNOLOGY; DENDRIMERS; HUMANS; NANOTECHNOLOGY;

EID: 63149128790     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Arima H., Kihara F., Hirayama F., Uekama K.: Enhancement of gene expression by polyamidoamine dendrimer conjugates with a-, β-, gcyclodextrins. Bioconjug. Chem., 2001; 12: 476-484
2. Balogh L., Bielinska A., Eichman J.D., Valluzzi R., Lee I., Baker J.R., Lawrence T.E., Khan M.K.: Dendrimer nanocomposites in medicine. Chimica Oggi/Chemistry Today, 2002; 20: 35-40
3. Battah S.H., Chee C.E., Nakanishi H., Gerscher S., MacRobert A.J., Edwards C.: Synthesis and biological studies of 5-aminolevulic acidcontaining dendrimers for photodynamic therapy. Bioconjug. Chem., 2001; 12: 980-988
4. Beezer A.E., King A.S., Martin I.K., Mitchel J.C., Twyman L.J., Wain C.F.: Dendrimer as potential drug carriers: encapsulation of acidic hydrophobes within water soluble PAMAM derivatives. Tetrahedron., 2003; 59: 3873-3880
5. Bhadra D., Bhadra S., Jain S., Jain N.K.: A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm., 2003; 257: 111-124
6. Bielinska A.U., Chen C., Johnson J., Baker J.R. Jr.: DNA complexing with polyamidoamine dendrimers: implications for transfection. Bioconjug. Chem., 1999; 10: 843-850
7. Bielinska A.U., Kukowska-Latallo J.F., Baker J.R.Jr.: The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA Biochim. Biophys. Acta., 1997; 1353: 180-190
8. Bielinska A., Kukowska-Latallo J.F., Johnson J., Tomalia D.A., Baker J.R. Jr.: Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res., 1996; 24: 2176-2182
9. Boas U., Heegaard P.M.: Dendrimers in drug research. Chem. Soc. Rev., 2004; 33: 43-63
10. Bourne N., Stanberry L.R., Kern E.R., Holan G., Matthews B., Bernstein D.I.: Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob. Agents Chemother., 2000; 44: 2471-2474
11. Brabander-van den Berg E.M., Meijer E.W.: Poly (propylene imine) dendrimers: large scale synthesis by heterogenously catalyzed hydrogenation. Angew Chem Int Ed Engl., 1993; 32: 1308-1311
12. Bryant L.H.Jr, Brechbiel M.W., Wu C., Bulte J.W., Herynek V., Frank J.A.: Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinum chelates. J. Magn. Reson. Imaging., 1999; 9: 348-352
13. Buhleier E., Wehner W., Vögtl F.: "Cascade" and "Nonskid-Chainlike" syntheses of molecular cavity and topologies. Synthesis, 1978; 2: 155-158
14. Bustos E.B., Jimenez M.G., Díaz-Sánchez B.R., Juaristi E., Chapman T.W., Godínez L.A.: Glassy carbon electrodes modified with composites of starburst-PAMAM dendrimers containing metal nanoparticles for amperometric detection of dopamine in urine. Talanta, 2007; 72: 1586-1592
15. Bustos E., Manríquez J., Orozco G., Godínez L.A.: Preparation, characterization, and electrocatalytic activity of surface anchored, Prussian Blue containing starburst PAMAM dendrimers on gold electrodes. Langmuir, 2005; 21: 3013-3021
16. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B.: Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev., 1999; 99: 2293-2352
17. Chen C.Z., Beck-Tan N.C., Dhurjati P., van Dyk T.K., LaRossa R.A., Cooper S.L.: Quaternary ammonium functionalized poly(propylene imine) dendrimers as effective antimicrobials: structure-activity studies. Biomacromolecules, 2000; 1: 473-480
18. Chen C.Z., Cooper S.L.: Interactions between dendrimer biocides and bacterial membranes. Biomaterials, 2002; 23: 3359-3368
19. Chen W., Turro N.J., Tomalia D.A.: Using ethidium bromide to probe the interactions between DNA and dendrimers. Langmuir, 2000; 16: 15-19
20. Dass C.R.: Vehicles for oligonucleotide delivery to tumours. J. Pharm. Pharmacol., 2002; 54: 3-27
21. Doubrovin M., Serganova I., Mayer-Kuckuk P., Ponomarev V., Blasberg R.G.: Multimodality in vivo molecular-genetic imaging. Bioconjug. Chem., 2004; 15: 1376-1388
22. Dufes C., Keith W.M., Proutski I., Bilsland A., Uchegbu I.F., Schätzlein A.G.: Synergistic anti-cancer gene medicine exploits intrinsic antitumour activity of cationic vector to cure established tumors. Cancer Res., 2005; 65: 8079-8084
23. Eichman J.D., Bielinska A.U., Kukowska-Latallo J.F., Baker J.R.Jr.: The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharm. Sci. Technol. Today, 2000; 3: 232-245
24. Franano F.N., Edwards W.B., Welch M.J., Brechbiel M.W., Gansow O.A. Duncan J.R.: Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinum complexes: evidence for gadolinium dissociation in vitro and in vivo. Magn. Reson. Imaging, 1995; 13: 201-214
25. Gebhart C.L., Kabanov A.V.: Evaluation of polyplexes as gene transfer agents. J. Control. Release, 2001; 73: 401-416
26. Godbey W.T., Wu K.K., Mikos A.G.: Tracking the intracellular path of poly(ethyleneimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA, 1999; 96: 5177-5181
27. Goula D., Remy J.S., Erbacher P., Wasowicz M., Levi G., Abdallah B., Demeneix B.A.: Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther., 1998; 5: 712-717
28. Hay B.P., Werner E.J., Raymond K.N.: Estimating the number of bound water in Gd(III) complexes revisited. Improved methods for the prediction of q-values. Bioconjug. Chem., 2004; 15: 1496-1502
29. Kabanov V.A., Sergeyev V.G., Pyshkina O.A., Zinchenko A.A., Zezin A.B., Joosten J.G.H., Brackman J., Yoshikawa K.: Interpolyelectrolyte complexes formed by DNA and astramol poly(propylene imine) dendrimers. Macromolecules, 2000; 33: 9587-9593
30. Klajnert B., Cortijo-Arellano M., Bryszewska M., Cladera J.: Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases. Biochem. Biophys. Res. Commun., 2006; 339: 577-582
31. Klajnert B., Przygodzki T.: Dendrymery w zastosowaniach terapeutycznych. Post. Biochem., 2003; 49: 290-297
32. Knapen J.W., van der Made A.W., de Wilde J.C., van Leeuwen P.W., Wijkens P., Grove D.M., van Koten G.: Homogeneous catalysts based on silane dendrimers functionalized with arylnickel(II) complexes. Nature, 1994; 372: 659-663
33. Kobayashi H., Kawamoto S., Jo S.K., Bryant H.L.Jr., Brechbiell M.W., Star R.A.: Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug. Chem., 2003; 14: 388-394
34. Kolhe P., Misra E., Kannan R.M., Kannan S., Lieh-Lai M.: Drug complexation in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int. J. Pharm., 2003; 259: 143-160
35. Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., Baker J.R. Jr.: Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. USA, 1996; 93: 4897-4902
36. Kukowska-Latallo J.F., Candido K.A., Cao Z., Nigavekar S.S., Majoros I.J., Thomas T.P., Balogh L.P., Khan M.K., Baker J.R. Jr.: Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res., 2005; 65: 5317-5324
37. Lai P.S., Lou P.J., Peng C.L., Pai C.L., Yen W.N., Huang M.Y., Young T.H., Shieh M.J.: Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. J. Control. Release, 2007; 122: 39-46
38. Langereis S., de Lussanet Q.G., van Genderen M.H.P., Backes W.H., Meijer E.W.: Multivalent contrast agents based on gadolinium-diethylenetriaminepentaacetic acid-terminated poly(propylene imine) dendrimers for magnetic resonance imaging. Macromolecules, 2004; 37: 3084-3091
39. Ma M., Cheng Y., Xu Z., Xu P., Qu H., Fang Y., Xu T., Wen L.: Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Eur. J. Med. Chem., 2007; 42: 93-98
40. Maeda H., Katayama K., Matsui R., Yamauchi Y., Ohmori H.: Surface improvement of glassy carbon electrode anodized in triethylene glycol and its application to electrochemical HPLC analysis of proteincontaining samples. Anal. Sci., 2000; 16: 293-298
41. Malik N., Evagorou E.G., Duncan R.: Dendrimer-platinate: A novel approach to cancer chemotherapy. Anticancer Drugs, 1999; 10: 767-776
42. Markatou E., Gionis V., Chryssikos G.D., Hatziantoniou S., Georgopoulos A., Demetzos C.: Molecular interactions between dimethoxycurcumin and Pamam dendrimer carriers. Int. J. Pharm., 2007; 339: 231-236
43. Na M., Yiyun C., Tongwen X., Yang D., Xiaomin W., Zhenwei L., Zhichao C., Guanyi H., Yunyu S., Longping W.: Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies. Eur. J. Med. Chem., 2006; 41: 670-674
44. Nagahori N., Lee R.T., Nishimura S., Page D., Roy R., Lee Y.C.: Inhibition of adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands. ChemBioChem, 2002; 3: 836-844
45. Newkome G.R., Yao Z.Q., Baker G.R., Gupta V.K.: Cascade molecules: A new approach to micelles, A27-arborol. J. Org. Chem, 1985; 50: 2003-2006
46. Nishiyama N., Stapert H.R., Zhang G.D., Takasu D., Jiang D.L., Nagano T., Aida T., Kataoka K.: Light-harvesting ionic dendrimer porphyrins as a new photosensitizers for photodynamic therapy. Bioconjug. Chem., 2003; 14: 58-66
47. Ohsaki M., Okuda T., Wada A., Hirayama T., Niidome T., Aoyagi H.: In vitro gene transfection using dendritic poly(L-lysine). Bioconjug. Chem., 2002; 13: 510-517
48. Padias A.B., Hall H.K.Jr., Tomalia D.A., McConnell J.R.: Starburst polyether dendrimers. J. Org. Chem., 1987; 52: 5305-5312
49. Qian L., Yang X.: Dendrimer films as matrices for electrochemical fabrication of novel gold/palladium bimetallic nanostructures. Talanta, 2008; 74: 1649-1653
50. Qin L., Pahud D.R., Ding Y., Bielinska A.U., Kukowska-Latallo J.F., Baker J.R.Jr., Bromberg J.S.: Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers. Hum. Gene Ther., 1998; 9: 553-560
51. Roberts H.C., Saeed M., Roberts T.P., Mühler A., Brasch R.C.: MRI of acute myocardial ischemia: comparing a new contrast agent, Gd-DTPA-24-cascade-polymer, with Gd-DTPA. J. Magn. Reson. Imaging, 1999; 9: 204-208
52. Sato N., Kobayashi H., Saga T., Nakamoto Y., Ishimori T., Togashi K., Fujibayashi Y., Konishi J., Brechbiel M.W.: Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. Clin. Cancer Res., 2001; 7: 3606-3612
53. Shcharbin D., Bryszewska M.: Complex formation between endogenous toxin bilirubin and polyamidoamine dendrimers: A spectroscopic study. Biochim. Biophys. Acta, 2006; 1760: 1021-1026
54. Schatzlein A.G., Zinselmeyer B.H., Elouzi A., Dufes C., Chim Y.T., Roberts C.J., Davies M.C., Munro A., Gray A.I., Uchegbu I.F.: Preferential liver gene expression with polypropyleneimine dendrimers. J. Control. Release, 2005; 101: 247-258
55. Shah D.S., Sakthivel T., Toth I., Florence A.T., Wilderspin A.F.: DNA tranfection and transfected cell viability using amphipathic asymmetric dendrimers. Int. J. Pharm., 2000; 208: 41-48
56. Sigal G.B., Mammen M., Dahmann G., Whitesides G.M.: Polyacrylamides bearing pendant alpha-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus: The strong inhibition reflects enhanced binding through cooperative polyvalent interactions. J. Am. Chem. Soc., 1996; 118: 3789-3800
57. Svenson S., Tomalia D.A.: Dendrimers in biomedical applications-reflections on the field. Adv. Drug Deliv. Rev., 2005; 57: 2106-2129
58. Takahashi M., Hara Y., Aoshima K., Kurihara H., Oshikawa T., Yamashita M.: Utilization of dendritic framework as a multivalent ligand: A functionalized gadolinium (III) carrier with glycoside cluster periphery. Tetrahedron Lett., 2000; 41: 8485-8488
59. Takahashi T., Kono K., Itoh T., Emi N., Takagishi T.: Synthesis of novel cationic lipids having polyamidoamine dendrons and their transfection activity. Bioconjug. Chem., 2003; 14: 764-773
60. Tang L., Zhu Y., Xu L., Yang X., Li C.: Amperometric glutamate biosensor based on self-assembling glutamate dehydrogenase and dendrimer-encapsulated platinum nanoparticles onto carbon nanotubes. Talanta, 2007; 73: 438-443
61. Tang M.X., Szoka F.C.: The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther., 1997; 4: 823-832
62. Tomalia D.A.: Architecturally driven properties based on the dendritic state. High Perform. Polym., 2001; 13: 1-10
63. Tomalia D.A., Baker H., Dewald J.R., Hall M., Kallos G., Martin S., Roeck J., Ryder J., Smith P.: A new class of polymers: Starburst-dendritic macromolecules. Polym. J., 1985; 17: 117-132
64. Tomalia D.A., Dvornic P.R.: What promises for dendrimers? Nature, 1994; 372: 617-618
65. Tomalia D.A., Uppuluri S., Swanson D.R., Li J.: Dendrimers as reactive modules for the synthesis of new structure-controlled, highercomplexity megamers. Pure Appl. Chem., 2000; 72: 2343-2358
66. Vandamme T.F., Brobeck L.: Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J. Control. Release, 2005; 102: 23-38
67. VivaGel™: in trials now to meet an urgent medical need. http://www.starpharma.com/data/STARPHARMA%20-%20VivaGel%20flyer.pdf (23.12.2008)
68. Wiener E.C., Auteri E.P., Chen J.W., Brechbiel M.W., Gansow O.A., Schneider D.S., Belford R.L., Clarkson R.B., Lauterbur P.C.: Molecular dynamics of ion-chelate complexes attached to dendrimers. J. Am. Chem. Soc., 1996; 118: 7774-7782
69. Yoo H., Juliano R.L.: Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res., 2000; 28: 4225-4231
70. Yordanov A.T., Lodder A.L., Woller E.K., Cloninger M.J., Patronas N., Milenic D., Brechbiel M.W.: Novel iodinated dendritic nanoparticles for computed tomography (CT) imaging. Nano Lett., 2002; 2: 595-599
71. Zanini D., Roy R.: Practical synthesis of Starburst PAMAM alphathiosialodendrimers for probing multivalent carbohydrate-lectin binding properties. J. Org. Chem., 1998; 63: 3486-3491
72. Zhuo R.X., Du B., Lu Z.R.: In vitro release of 5-fluorouracil with cyclic core dendritic polymer. J. Controlled Release, 1999; 57: 249-257
73. Zinselmeyer B.H., Mackay S.P., Schatzlein A.G., Uchegbu I.F.: The lower-generation polypropylenimine dendrimers are effective genetransfer agents. Pharm. Res., 2002; 19: 960-967